TP53 and small cell lung carcinoma: reported that LCNECs with co-mutation of TP53 and RB1 (SCLC-like) were significantly enriched in cases with a Ki-67 ≧55%, while the tumors with KRAS mutations were enriched in cases with Ki-67 <55% (39).